Free Trial
NASDAQ:BCTXW

BriaCell Therapeutics (BCTXW) Stock Price, News & Analysis

BriaCell Therapeutics logo
$0.10 +0.00 (+0.10%)
As of 09:59 AM Eastern
This is a fair market value price provided by Polygon.io. Learn more.

About BriaCell Therapeutics Stock (NASDAQ:BCTXW)

Key Stats

Today's Range
$0.08
$0.10
50-Day Range
$0.09
$0.17
52-Week Range
$0.07
$1.38
Volume
9,462 shs
Average Volume
102,494 shs
Market Capitalization
N/A
P/E Ratio
N/A
Dividend Yield
N/A
Price Target
N/A
Consensus Rating
N/A

Company Overview

BriaCell Therapeutics Corp. operates as a Phase 3 biotechnology company transforming cancer care with its novel cellular immunotherapies. It is conducting a pivotal Phase 3 clinical trial in advanced breast cancer with its Bria-IMT in combination with an immune check point inhibitor. It is also developing personalized off-the-shelf treatments for breast cancer, prostate cancer, and other cancers. The company has a collaboration with Incyte Corporation to evaluate combination of the Bria-IMT. BriaCell Therapeutics Corp. is based in West Vancouver, Canada.

Remove Ads
Receive BCTXW Stock News and Ratings via Email

Sign-up to receive the latest news and ratings for BriaCell Therapeutics and its competitors with MarketBeat's FREE daily newsletter.

BCTXW Stock News Headlines

Trump’s betrayal exposed
Trump’s Final Reset Inside the shocking plot to re-engineer America’s financial system…and why you need to move your money now.
See More Headlines

BCTXW Stock Analysis - Frequently Asked Questions

BriaCell Therapeutics' stock was trading at $0.2895 on January 1st, 2025. Since then, BCTXW stock has decreased by 64.8% and is now trading at $0.1020.
View the best growth stocks for 2025 here
.

Shares of BCTXW stock can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include Charles Schwab, E*TRADE, Fidelity, and Vanguard Brokerage Services.

Industry, Sector and Symbol

Stock Exchange
NASDAQ
Sector
Medical
Industry
Biotechnology
Sub-Industry
Pharmaceutical Products
Current Symbol
NASDAQ:BCTXW
Web
N/A
Fax
N/A
Employees
8
Year Founded
N/A

Profitability

Trailing P/E Ratio
N/A
Forward P/E Ratio
N/A
P/E Growth
N/A
Pretax Margin
N/A

Debt

Sales & Book Value

Annual Sales
N/A
Price / Cash Flow
N/A
Price / Book
N/A

Miscellaneous

Free Float
N/A
Optionable
Not Optionable
Beta
N/A
12 Stocks Corporate Insiders are Abandoning Cover

If a company's CEO, COO, and CFO were all selling shares of their stock, would you want to know? MarketBeat just compiled its list of the twelve stocks that corporate insiders are abandoning. Complete the form below to see which companies made the list.

Get This Free Report

This page (NASDAQ:BCTXW) was last updated on 4/4/2025 by MarketBeat.com Staff
From Our Partners